Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Oct 21, 2010 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Mar 17, 2011 gilman alfred g Director Automatic Sell 18,347 38.92
Mar 17, 2011 gilman alfred g Director Sell 1,700 38.97
Mar 17, 2011 gilman alfred g Director Option Execute 30,000 18.80 - 28.81
Apr 29, 2011 gilman alfred g Director Acquisition (Non Open Market) 20,000 n/a
May 2, 2011 gilman alfred g Director Automatic Sell 20,000 50.68 - 51.11
Dec 13, 2011 gilman alfred g Director Disposition (Non Open Market) 11,875 n/a
Feb 14, 2012 gilman alfred g Director Disposition (Non Open Market) 3,266 111.01
Feb 15, 2012 gilman alfred g Director Sell 26,734 109.56
Feb 14, 2012 gilman alfred g Director Option Execute 30,000 9.17 - 15.01
Aug 7, 2012 gilman alfred g Director Sell 15,000 139.56
Aug 7, 2012 gilman alfred g Director Option Execute 15,000 15.80
May 6, 2013 gilman alfred g Director Sell 30,000 260.41 - 264.82
May 6, 2013 gilman alfred g Director Option Execute 30,000 19.69 - 23.84
Jan 14, 2014 gilman alfred g Director Automatic Sell 5,000 300.00
Jan 14, 2014 gilman alfred g Director Option Execute 5,000 18.61
Feb 11, 2014 gilman alfred g Director Automatic Sell 5,000 320.00
Feb 11, 2014 gilman alfred g Director Option Execute 5,000 18.61
Feb 21, 2014 gilman alfred g Director Automatic Sell 5,000 340.00
Feb 21, 2014 gilman alfred g Director Option Execute 5,000 18.61
Showing 181-200 of 1043 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)